Keyphrases
Indonesia
100%
Surabaya
54%
COVID-19
53%
Helicobacter Pylori (H. pylori)
48%
AIDS/HIV
28%
Helicobacter Pylori Infection
26%
Human Immunodeficiency Virus Type 1 (HIV-1)
23%
Chronic Kidney Disease
21%
Meta-analysis
19%
Type 2 Diabetes Mellitus (T2DM)
19%
Indonesian
17%
Chronic Kidney Disease Patients
16%
Systematic Meta-analysis
16%
Type 2 Diabetic Patients
14%
Antiretroviral Therapy
14%
Hemodialysis
13%
Type 1 Diabetes Mellitus (T1DM)
12%
Risk Factors
12%
HIV Patients
11%
Hypertension
11%
CRF01_AE
11%
General Hospital
10%
CagA
10%
Gastric Cancer
10%
Drug Resistance mutations
10%
COVID-19 Patients
9%
Disease Activity
9%
Interleukin-6
9%
East Java Indonesia
8%
Hemodialysis Patients
8%
Frailty
8%
Nave
8%
Inflammation
7%
COVID-19 Pandemic
7%
Sarcopenia
7%
Comorbidity
7%
Antibiotics
7%
Type 2 Diabetes Mellitus Patients
7%
Medical Records
7%
Oxidative Stress
7%
Hemoglobin A1c (HbA1c)
7%
Ethyl Acetate
6%
Psoriatic Arthritis
6%
Genotype
6%
AIDS Patients
6%
Tuberculosis
6%
Clinical Manifestations
6%
Referral Hospital
6%
D-dimer
6%
Systemic Lupus Erythematosus
6%
C-reactive Protein
6%
Insulin Resistance
6%
Clinical Outcomes
6%
Intact Parathyroid Hormone (iPTH)
6%
Hepatitis B Virus
6%
Dengue Fever
6%
Spondyloarthritis
6%
Sepsis
6%
Body Mass Index
6%
Fungus Comb
6%
Maintenance Hemodialysis Patients
6%
Obesity
5%
Pulmonary Tuberculosis
5%
Clinical Characteristics
5%
Non-dialysis Chronic Kidney Disease
5%
Indomalaya
5%
Chronic Myeloid Leukemia
5%
East Asia
5%
Dyspepsia
5%
Infected Individual
5%
Proton Pump Inhibitors
5%
Vaccination
5%
No Significant Difference
5%
Confidence Interval
5%
Hepatitis B
5%
Human Immunodeficiency Virus/acquired Immunodeficiency Syndrome
5%
Antibiotic Resistance
5%
Breast Cancer Patients
5%
Patients with Diabetes Mellitus
5%
Macrotermes Gilvus Hagen
5%
Co-infection
5%
Inflammatory Cytokines
5%
COVID-19 Vaccine
5%
High-sensitivity C-reactive Protein (hs-CRP)
5%
Non-Hodgkin Lymphoma
5%
Gene Polymorphism
5%
Termites
5%
Clarithromycin
5%
Arthritis Patients
5%
Critically Ill COVID-19 Patients
5%
Estimated Glomerular Filtration Rate
5%
Healthcare Workers
5%
Glycemic Control
5%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
58%
HIV
39%
Helicobacter Pylori
37%
Infection
33%
Coronavirinae
30%
Prevalence
25%
Chronic Kidney Failure
23%
Hemodialysis
22%
Non Insulin Dependent Diabetes Mellitus
19%
Diabetes Mellitus
16%
Cross-Sectional Study
15%
Drug Resistance
13%
Inflammation
12%
C Reactive Protein
12%
SARS Coronavirus
11%
Comorbidity
10%
Retrospective Study
10%
Helicobacter Infection
9%
Human Immunodeficiency Virus 1
9%
Clarithromycin
8%
Interleukin 6
8%
Metronidazole
8%
Disease Activity
8%
Chemotherapy
8%
Abdominal Cancer
7%
Frailty
7%
Antimicrobial Resistance
7%
Dengue
7%
Sepsis
7%
Antibiotics
7%
Sarcopenia
7%
Biological Marker
6%
Dengue Virus
6%
COVID-19 Vaccine
6%
Spondylarthritis
6%
Nonhodgkin Lymphoma
6%
D Dimer
6%
Hemoglobin A1c
6%
Levofloxacin
5%
Antivirus Agent
5%
Human Immunodeficiency Virus Infection
5%
Cohort Study
5%
Vitamin D
5%
Cardiovascular Disease
5%
Mortality Rate
5%
Virus Infection
5%
Hepatitis B Virus
5%
Medicine and Dentistry
COVID-19
46%
Helicobacter Pylori
29%
Infection
27%
Chronic Kidney Disease
18%
Diseases
18%
Prevalence
17%
Systematic Review
16%
Diabetes Mellitus
16%
Human Immunodeficiency Virus
16%
Meta-Analysis
13%
Diagnosis
12%
Cross Sectional Study
11%
Hemodialysis
10%
Maturity Onset Diabetes of the Young
9%
Lymphocyte
8%
Retrospective Study
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Human Immunodeficiency Virus 1
8%
Abdominal Cancer
8%
Helicobacter Infection
7%
Comorbidity
7%
Drug Resistance
6%
Liver Cirrhosis
6%
Patient with Diabetes
6%
Biological Marker
6%
Case Presentation
6%
Sepsis
6%
Chronic Myelogenous Leukemia
5%
C Reactive Protein
5%
Platelet
5%
Health Care Cost
5%
Mixed Infection
5%
Diabetes
5%
COVID-19 Vaccine
5%
Non-Hodgkin Lymphoma
5%
Stomach Acid
5%
Antiretroviral Therapy
5%
Sarcopenia
5%